Atypical cadherin CELSR2 acts as a therapeutic target for glioma through WNT3A/β-catenin signaling
8.5
来源：
Nature
关键字：
siRNA
发布时间：
2025-11-03 23:54
摘要：
CELSR2 is identified as a critical regulator in glioma development, promoting tumor growth through WNT3A/β-catenin signaling. The study demonstrates that knocking down CELSR2 inhibits glioma cell proliferation and alters key signaling pathways. Additionally, the use of magnetic nanoparticles for targeted delivery of CELSR2-siRNA shows promise as a novel therapeutic strategy for glioma treatment, potentially improving patient outcomes.
原文：
查看原文
价值分投票
评分标准
新闻价值分采用0-10分制，综合考虑新闻的真实性、重要性、时效性、影响力等多个维度。
评分越高，表示该新闻的价值越大，越值得关注。
价值维度分析
domain_focus
1.0分+1.0分
business_impact
0.5分+0.5分
scientific_rigor
1.5分+1.5分
timeliness_innovation
1.5分+1.5分
investment_perspective
2.5分+2.5分
market_value_relevance
1.0分+1.0分
team_institution_background
0.5分+0.5分
technical_barrier_competition
1.0分+1.0分
关键证据
CELSR2 expression is significantly increased in glioma tissues and correlates with poor patient survival.
CELSR2 knockdown reduces glioma cell proliferation and alters Wnt/β-catenin signaling.
MNPs-loaded CELSR2-siRNA effectively inhibits glioma growth in vivo.
真实性检查
否
AI评分总结
CELSR2 is identified as a critical regulator in glioma development, promoting tumor growth through WNT3A/β-catenin signaling. The study demonstrates that knocking down CELSR2 inhibits glioma cell proliferation and alters key signaling pathways. Additionally, the use of magnetic nanoparticles for targeted delivery of CELSR2-siRNA shows promise as a novel therapeutic strategy for glioma treatment, potentially improving patient outcomes.